JSW MG Motor India will launch four new models this year, and is planning to invest between 3,000 crore-4,000 crore in the country over the next couple of years. The new models include a plug-in hybrid, an electric vehicle, the Majestor SUV and one additional model yet to be disclosed.
Eyewear retailer Lenskart Solutions is gearing up to launch its initial public offering (IPO) on October 31, aiming to raise Rs 2,150 crore through a fresh issue of shares. This marks its much-awaited entry into the public markets.
The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
A series of explosions rocked Lebanon and Beirut on Wednesday with the health ministry confirming nine deaths while news agencies put the toll at higher. The fresh round of blast came just a day after a deadly attack involving exploding pagers claimed the lives of at least 12 people.
Disney Star is mulling legal actions against Zee Entertainment for backing out from a $1.4 billion sub-licensing agreement for TV broadcast of international cricket matches in India, according to industry sources. This could brew another legal trouble for Zee Entertainment Enterprises Ltd (ZEEL), which is already facing an arbitration plea by Sony Group at the Singapore International Arbitration Centre, claiming $90 million for breach of conditions of their merger agreement. Disney Star, an Indian subsidiary of media conglomerate The Walt Disney Company, is working on its strategy over the development, said industry sources.
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.
Modi and Biden will have a one-on-one meeting in the Oval Office of the White House on Thursday before holding high-level talks.
The court said if employees continue to hold on to flats then Air India Asset Holding Company would not be able to monetize the land to reduce the burden of Air India's debt.
A day after announcing withdrawal from its chip-making JV with Indian conglomerate Vedanta, Foxconn on Tuesday said it is working on plans to apply for incentives under semiconductor and display fab programme, as the contract manufacturer pledged its commitment to India. The Taiwanese electronics manufacturing giant said it has been actively reviewing landscape for optimal partners. The comment assumes significance as Foxconn has pulled out from the $19.5 billion semiconductor JV with Vedanta.
'Policy-sensitive sectors will wait and watch, but policy-agnostic areas will continue based on normal consumption demand.'
Taiwanese electronic contract manufacturer Foxconn on Monday said it has decided to pull out of semiconductor joint venture with Indian conglomerate Vedanta, according to a statement. Foxconn said it is "working to remove the Foxconn name from what now is a fully-owned entity of Vedanta". "Foxconn has no connection to the entity and efforts to keep its original name will cause confusion for future stakeholders," Hon Hai Technology group (Foxconn) said.
'This is a first-of-its-kind partnership in the Indian media & entertainment landscape, and this association with Disney Star reflects our sharp, strategic vision for the sports business India.'
Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.
Unlike Israeli company NSO, whose sale of Pegasus cyber tech grabbed worldwide attention, and other manufacturers of offensive-cyber products, Cellebrite operates in a grey area between security exports and civilian ones.
In a major expansion into sportswear and lifestyle wear segment, the Kumar Mangalam Birla-led Aditya Birla Fashion & Retail has signed a long-term licensing agreement with Authentic Brand Group of New York, which has the marketing and branding rights of Reebok, to run the operations of the global sportswear, athletic and lifestyle major in the country and ASEAN markets. The new agreement between the largest domestic multi-brand fashion retailer and Authentic Brand is an extension of their existing relationship as ABFRL already markets and sells some ABG brands like Forever 21. The agreement follows the global transfer of ownership of the Reebok brand from Adidas to ABG, which is expected to close in the first quarter of 2022.
Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.
The revenue for Q1 FY21 came in at Rs 23,939 crore, up 15.4 per cent from year-ago period.
The company said this was 'important' to reinforce the 'complete disassociation' from its erstwhile promoters -- Malvinder and Shivinder Singh.
The Central Bureau of Investigation has intensified its probe in 2G spectrum allocation during the National Democratic Alliance regime when late Pramod Mahajan was the telecom minister and asked the Department of Telecom to provide license agreements with all telecom providers between 2001 and 2007.
The government on Wednesday notified its decision to permit 100 per cent foreign direct investment (FDI) under automatic route in the telecom services sector. In a press note, the Department for Promotion of Industry and Internal Trade (DPIIT) said foreign investment in telecom services will be subject to the condition of Press Note 3 of 2020. Accordingly, cases requiring prior government approval under the provisions of Press Note 3 will continue to be in place.
Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.
Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.
If you have moved into a new city and are in search of a rented accommodation, here's what you must know.
License agreements are expected to be signed with all the nine LoI holders in the next two days and spectrum would be allotted subsequently, to begin with, in those circles where it is available readily, telecom ministry officials said. Four firms have got LoIs for pan-India operations while others have got for additional circles. The nine companies are Unitech, Datacom, Shyam Telelink, Loop Telecom, S Tel, Swan Telecom, Spice Telecom, Idea and Tata Teleservices.
Biocon Ltd on Wednesday said it has signed a product licensing agreement with Bentley Pharmaceuticals, Inc, a technology-based specialty pharmaceutical and drug delivery company for Bentley's intranasal spray formulation for administering insulin.
When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.
Cipla is among the three Indian companies that signed a non-exclusive licensing agreement with US-based Gilead Sciences to make and distribute the latter's repurposed Ebola drug Remdesivir in 127 countries including India.
The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.
Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.
On production capacity of Covishield, the vaccine being manufactured and supplied by Serum in India under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and always try to increase it further.
Indrani laughed loudly. She looked like the cat that got the cream, smiling gaily. Vaihayasi Pande Daniel reports from the Sheena Bora murder trial.
At the heart of the current controversy is the government's FDI rule
A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.
The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.
Goal-line technology providers GoalRef and Hawk-Eye have been authorised to install their systems worldwide after signing licence agreements with FIFA, soccer's world governing body said on Tuesday.
Have you ever been hangry? Or met Aunt Flo?
The move is meant to curb or reverse the export of India's financial markets to overseas trading platforms.
Maharashtra government on Wednesday informed the Bombay high court that all municipal corporations in the state have been asked to incorporate the provisions of Cigarette and Other Tobacco Products (Prohibition) Act in the license agreements of restaurants and eating joints, which means a complete ban on sale of hookah and other tobacco products at these places.
Sistema Shyam TeleServices Ltd is a venture involving equity participation by Sistema of Russia, the Russian Federation and the Shyam Group of India.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances